Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patients
Thursday, July 17, 2008 - 05:28
in Health & Medicine
A medication called cinacalcet—an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD)—works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN).
Read the whole article on Physorg
More from Physorg
Related
- Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patientsThu, 17 Jul 2008, 6:28:44 EDT
- Controlling bone disease improves survival of hemodialysis patientsWed, 2 Jul 2008, 13:08:09 EDT
- Before starting dialysis, patients need nephrologist careWed, 25 Mar 2009, 17:58:44 EDT
- Simple lab test for bone disease linked to risk of death in dialysis patientsThu, 31 Jul 2008, 6:07:54 EDT
- For dialysis patients, skinny is dangerousSat, 31 Oct 2009, 14:37:04 EDT